Search company, investor...

Predict your next investment

Angel Investor (Individual)

Investments

1

Portfolio Exits

1

About David Ebsworth

Headquarters Location

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Latest David Ebsworth News

Verona Pharma has compound with 'massive potential to impact lives of COPD and asthma patients'

Dec 2, 2019

Verona Pharma PLC ( LON:VRP ) chairman David Ebsworth tells Proactive London's Andrew Scott the company's made 'massive progress' in the last few years. ''When we started it was really three or four people, we didn't have a  lot of money, we had early data and over the last five years we've raised significant capital, hired some excellent people to supplement the team and delivered a number of different clinical trials which have shown we have a compound that has massive potential to impact the lives of patients with COPD as well as with asthma or cystic fibrosis.'' ''I'm actually quite disappointed in the current share price''. ''I think there's a massive upside.''. ''Since I joined the company as chairman I've probably spent £300k buying shares - £125k of that this year to demonstrate my belief in the company and our programme''. Quick facts: Verona Pharma

David Ebsworth Investments

1 Investments

David Ebsworth has made 1 investments. Their latest investment was in Small Pharma as part of their Seed on April 4, 2017.

CBI Logo

David Ebsworth Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/7/2017

Seed

Small Pharma

$1.03M

Yes

3

Date

4/7/2017

Round

Seed

Company

Small Pharma

Amount

$1.03M

New?

Yes

Co-Investors

Sources

3

David Ebsworth Portfolio Exits

1 Portfolio Exit

David Ebsworth has 1 portfolio exit. Their latest portfolio exit was Small Pharma on May 06, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

5/6/2021

Reverse Merger

$99M

2

Date

5/6/2021

Exit

Reverse Merger

Companies

Valuation

$99M

Acquirer

Sources

2

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.